AVDLHealthcareMid-Cap

AVADEL PHARMACEUTICALS PLC Insider Trading Activity

Every SEC Form 4 insider transaction reported for AVADEL PHARMACEUTICALS PLC (AVDL), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are AVDL insiders buying or selling?

AVADEL PHARMACEUTICALS PLC insiders reported 45 open-market buys ($4.4M) and 9 sells ($235.7M) across 54 Form 4 filings — a net selling position of $231.3M.

Source: SEC EDGAR Form 4

Key Statistics (as of Feb 18, 2026)

Total Form 4 filings
54
SEC EDGAR
Insider filers
13
Insider buys (45)
$4.4M
Insider sells (9)
$235.7M

Insider sentiment

Net selling

Net insider flow of $231.3M in net selling.

Recent AVDL insider transactions

DateInsiderRoleTypeSharesPriceValue
Feb 18, 2026Weiss Asset Management LPOtherSale11.1M$21.00$233.4M
Jan 22, 2025Linda PalczukDirectorPurchase5.0K$7.93$39.6K
Jan 14, 2025Peter J. ThorntonDirectorPurchase10.0K$8.05$80.5K
Jan 14, 2025Eric J EndeDirectorPurchase30.0K$7.84$235.2K
Dec 16, 2024Thomas S MchughChief Financial OfficerPurchase2.3K$10.44$24.0K
Dec 12, 2024Thomas S MchughChief Financial OfficerPurchase5.0K$10.49$52.4K
Dec 10, 2024Gregory J DivisChief Executive OfficerPurchase10.0K$9.97$99.7K
Dec 10, 2024Geoffrey Michael GlassDirectorPurchase20.3K$9.84$199.6K
Dec 10, 2024Linda PalczukDirectorPurchase3.0K$10.19$30.6K
Jan 16, 2024Thomas S MchughChief Financial OfficerPurchase2.0K$14.50$29.0K
Dec 29, 2023Mark Anthony MccamishDirectorSale75.0K$14.53$1.1M
Aug 15, 2023Mark Anthony MccamishDirectorSale29.0K$14.93$432.6K
Aug 14, 2023Thomas S MchughChief Financial OfficerPurchase2.0K$14.45$28.9K
Aug 11, 2023Geoffrey Michael GlassDirectorPurchase14.0K$13.40$187.6K
Aug 10, 2023Gregory J DivisChief Executive OfficerPurchase10.0K$13.20$132.0K
May 19, 2023Eric J EndeDirectorPurchase13.0K$13.93$181.1K
May 10, 2023Linda PalczukDirectorPurchase2.5K$14.76$36.9K
Dec 28, 2022Linda PalczukDirectorPurchase2.0K$7.20$14.4K
Nov 30, 2022Thomas S MchughChief Financial OfficerPurchase5.0K$7.80$39.0K
Nov 23, 2022Eric J EndeDirectorPurchase20.0K$7.80$156.1K
Jun 3, 2022Geoffrey Michael GlassDirectorPurchase45.0K$2.14$96.3K
Jun 2, 2022Geoffrey Michael GlassDirectorPurchase45.0K$2.14$96.3K
Jun 1, 2022Eric J EndeDirectorPurchase35.0K$2.23$77.9K
May 31, 2022Linda PalczukDirectorPurchase10.0K$1.60$16.0K
May 31, 2022Thomas S MchughChief Financial OfficerPurchase50.0K$2.14$106.9K

Showing the 25 most recent of 54 Form 4 filings for AVADEL PHARMACEUTICALS PLC.

Most active AVDL insiders

  • Eric J Ende10 filings
  • Thomas S Mchugh9 filings
  • Geoffrey Michael Glass7 filings
  • Linda Palczuk7 filings
  • Gregory J Divis6 filings

Ask anything about AVDL insider activity

Use Trabud's AI agent to query AVADEL PHARMACEUTICALS PLC's Form 4 history in plain English — "Show me AVDL CEO purchases this year" or compare it against any other ticker.

Open the AI agent

AVDL insider trading FAQ

Are AVADEL PHARMACEUTICALS PLC insiders buying or selling?

Across 54 SEC Form 4 filings, AVADEL PHARMACEUTICALS PLC (AVDL) insiders reported 45 open-market purchases totaling $4.4M and 9 sales totaling $235.7M. That is a net selling position of $231.3M.

How many insiders trade AVDL stock?

13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AVADEL PHARMACEUTICALS PLC. The most recent filing was accepted on Feb 18, 2026.

Where does Trabud get AVDL insider trading data?

All AVDL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content